Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $60.30, moving +1.88% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.01%. On ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Why does this time of year feel so apt for ghost ... Another celebrity charity show with £50,000 up for grabs; the line-up waiting to be damned by faint praise from host Romesh Ranganathan ...

DaVita, Inc. (NYSE: DVA) has witnessed strong momentum year to date, with its shares up 47.3% compared with the industry's growth of 14.8%. The S&P 500 composite has risen 19.5% in the same period.

From mind-blowing tidal surges to the Earth moving, clichés abound when it comes to orgasms. But we’re not all in the throes of ecstasy. According to digital health platform Hims & Hers’s 2023 report, ...